News

Dr. Roberta Diaz Brinton Featured at Alzheimer’s Drug Discovery Foundation Virtual Event, May 6

Friday, May 1, 2020

TUCSON, Ariz. – The 10th annual Great Ladies Luncheon, held by the Alzheimer’s Drug Discovery Foundation, will take place as a virtual event on May 6, 2020, celebrating a decade of science and fashion and raising money for Alzheimer’s disease research.

The UArizona Center for Innovation in Brain Science is working to develop the first regenerative therapeutic to regenerate the degenerated brain.Host of this year’s event, Andrea Mitchell, MSNBC/NBC News anchor and commentator, will moderate the online symposium and luncheon to conquer Alzheimer’s disease. Roberta Diaz Brinton, PhD, director of the University of Arizona Center for Innovation in Brain Science, will join ADDF Director Howard Fillit, MD, to discuss several topics, including:

  • The impact COVID-19 is having on Alzheimer’s patients and the ongoing quest for a cure;
  • The current state of Alzheimer’s research and major milestones of the past 10 years;
  • Dr. Brinton’s research on why the female brain is at greater risk for developing Alzheimer’s disease.

The event gets under way at 7:30 a.m. (MST/Arizona Time), with Dr. Brinton’s remarks and Q&A session from 7:40 a.m. to 8:10 a.m.

Roberta Diaz Brinton, PhDDr. Brinton is an internationally recognized expert on women and their risk of Alzheimer’s disease. Her scientific discoveries have led to the development of innovative therapeutics to prevent, delay and treat the disease. She is currently developing the first regenerative therapeutic to regenerate the degenerated brain.

To register to view the free online event: https://www.alzdiscovery.org/support-tenth-annual-great-ladies-luncheon.

Alzheimer's disease is a progressive neurodegenerative disorder that causes brain cells to waste away and die. It also is the most common cause of dementia – a continuous decline in memory, thinking, behavioral and social skills that disrupts a person's ability to function independently. As many as 5.5 million Americans age 65 and older may suffer from the disease. Learn more at the Alzheimer’s Association or the National Institute on Aging, a unit of the National Institute of Health.

# # #

NOTE: Photo available upon request.

About the Center for Innovation in Brain Science
The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a neurodegenerative disease. The CIBS team is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS (or Lou Gehrig’s Disease). With expertise spanning discovery, translational, regulatory and clinical science, CIBS is shifting the research paradigm as one of the nation’s leading research centers, pioneering patient-inspired, data-driven approaches to find cures for Alzheimer’s and other neurodegenerative diseases. The CIBS mission is to create innovations in brain science of the future for those who need a cure today. Find out more about how CIBS is achieving the vision of vibrant brains that last a lifetime. For more information: cibs.uahs.arizona.edu (Follow us: Facebook | Twitter).

About the University of Arizona Health Sciences
The University of Arizona Health Sciences is the statewide leader in biomedical research and health professions training. UArizona Health Sciences includes the Colleges of Medicine (Tucson and Phoenix), Nursing, Pharmacy, and the Mel and Enid Zuckerman College of Public Health, with main campus locations in Tucson and the Phoenix Biomedical Campus in downtown Phoenix. From these vantage points, Health Sciences reaches across the state of Arizona, the greater Southwest and around the world to provide next-generation education, research and outreach. A major economic engine, Health Sciences employs nearly 5,000 people, has approximately 4,000 students and 900 faculty members, and garners $200 million in research grants and contracts annually. For more information: uahs.arizona.edu (Follow us: Facebook | Twitter | YouTube | LinkedIn | Instagram).

Original Story Link: